Concepedia

David Gebhart

DG

5

Publications

122

Citations

5

H-Index

2020

Active since

Affiliations

Enable Biosciences (United States)(Current)

Stanford University

California Department of Public Health

David Gebhart is an author at Enable Biosciences (United States) specializing in diabetes, autoimmune disease, and immunology.

Top concepts

Publications per year

2020–2022

5

Publications

5

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

Felipe de Jesus Cortez, David Gebhart, Peter V. Robinson et al. · PLoS ONE · 2020 · 46 citations · Full text

, , +16

Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease

A. R. Lind, Felipe de Jesus Cortez, Anita Ramelius et al. · Journal of Immunological Methods · 2022 · 31 citations · Full text

, , +20

CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021

Megha Mehrotra, Esther Lim, Katherine Lamba et al. · Open Forum Infectious Diseases · 2022 · 18 citations · Full text

Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies

Felipe de Jesus Cortez, David Gebhart, Devangkumar Tandel et al. · SLAS TECHNOLOGY · 2022 · 14 citations · Full text

Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR

Kenneth Danh, Donna Grace Karp, Malvika Singhal et al. · Nature Communications · 2022 · 13 citations · Full text

Rows per page

1–5 of 5